{"id":126,"name":"Novo","createDateTime":"2026-09-30T01:06:36.122Z","industry":"Pharmaceutical","country":"Australia","tagline":"Lasting health starts now","website":"https://www.novonordisk.com.au/","logoImage":"c96bed8528aaae2ae2d379c65c38f057d1c1b59251f98d2cd0b29ad1","logoImageThumbnail":"3a5c29ba7d9f777b4983bdf271ec88b03e1b995ea22b0f6c74e1da85","bannerImage":"c9d6febe8d3bd5471b2c59a3156052cbe03ca40df57df9b333cfdecb","about":"A global healthcare company with more than 90 years of innovation in treatment for serious chronic disease, like diabetes and obesity.","addressLine1":"Level 10, 118 Mount Street","addressLine2":null,"city":"North Sydney","state":"New South Wales","postcode":"2060","followerCount":3,"education":[{"id":1392,"name":"Closing Practice Gaps: Improving T2D in General Practice","image":"f4a94cac168e327411186627cefdcfe4449dee70518fd795322a41cc","imageThumbnail":"318076efda9b8efbe7eac1f31dc055694cea9b5eb3ab554a1eb61a83","type":"zoom-webinar","startDateTime":"2026-11-11T08:30:00.000Z","durationSecs":5400,"associationEducationTypes":["EA","MO","RP"]},{"id":1403,"name":"From recommendation to patient agreement: Treatment conversations in T2D","image":"00bbd36817cf902b7b5c09186f9b78017595a5b4c107923d6feff229","imageThumbnail":"10981eb9a8d37d9cbc2539c6a1985050e65cda9e3591f1183d371344","type":"video","startDateTime":null,"durationSecs":537,"associationEducationTypes":["RP"]},{"id":1402,"name":"Above target: When does HbA1c require action?","image":"94cde287e85176375b48b2b2a9513c04eca617c59ba74ec2eec35687","imageThumbnail":"4e1554b7cbc5953361ac93d3c3e542740e5edbb314b849e6da6ab511","type":"video","startDateTime":null,"durationSecs":699,"associationEducationTypes":["RP"]},{"id":1401,"name":"Impact of HbA1c and comorbidities on choosing the next treatment","image":"17f7ea6b9f974b4d94b4ce84e95f17cd74ad107973060b32fa993ee0","imageThumbnail":"52eaa51ca329c0f7d9e18bf6c6ab0472e879fe932375ccc9d028de3a","type":"video","startDateTime":null,"durationSecs":628,"associationEducationTypes":["RP"]},{"id":1400,"name":"Navigating SGLT2i, GLP-1 RA, PBS pathways","image":"010c9d8fce40ea99c304277a2c29c50ad1ed4048aa180a10c790cae5","imageThumbnail":"46e4a69f171786a370f523a871c5aa75a81d9128eb9532d372266963","type":"video","startDateTime":null,"durationSecs":536,"associationEducationTypes":["RP"]},{"id":1399,"name":"The overdue patient: Recall, review, treat","image":"b6ec463780531192c5014e0beb6b91984bd5bdcea47e2e558b74247d","imageThumbnail":"0396eb1c06fb056c9cb9c81f66ec9f176d9b84de40578ebf86907f1a","type":"video","startDateTime":null,"durationSecs":565,"associationEducationTypes":["RP"]},{"id":1398,"name":"Starting a GLP-1 RA: Counselling for success","image":"489cfb351b34059332e0c10ce2bae28b17d6b157abc3b6c3de32c816","imageThumbnail":"0d7d06a588a7c1cb4702c8cbf3ab69b5b0b8f788709c4ec91e6babf7","type":"video","startDateTime":null,"durationSecs":485,"associationEducationTypes":["RP"]},{"id":1397,"name":"The role of GPL-1 RAs in T2D","image":"81ce79063f6a67aeb0f3b1b417f7feca41e201c725eab9ed8875f0cd","imageThumbnail":"f228dfcb3a1e21cf3b7e992849e9664820bcdb7b22845e1e2187cf2c","type":"video","startDateTime":null,"durationSecs":590,"associationEducationTypes":["RP"]}]}